InvestorsHub Logo
Followers 16
Posts 1062
Boards Moderated 0
Alias Born 09/01/2019

Re: None

Thursday, 06/03/2021 5:45:53 PM

Thursday, June 03, 2021 5:45:53 PM

Post# of 16698
We wont be at the EOP2 FDA Meeting. Probably Dr MW wont be either, to represent his well paid for Work. Other's will be presenting OUR case to the FDA that have gleaned 'Significant' Data missed (?) by the past CSO...
Our Strongest cards for Ifenprodil and AGN. IMO.

I'm INVESTED in the bet AGN CEO C.M. is able to pull off a success. Defined as a Phase 3 directed at patients existing with low O2 / ALI / and maybe Pulmonary Fibrosis all from COVID. Now THAT would be a Marketable Hand...GLTA...

BTW, other popular companies are applying for EUA with less than 200 patient CTs. None with the sound science and Safety of Ifenprodil. IMO.

The latrine lawyering skills of some are impressive. Most LLs post with an IMO... IMO...